| NCT ID | NCT05959551 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Manitoba |
| Condition | Electricity; Effects |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2023-07-01 |
| Primary Completion | 2026-08-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2023-07-01 with a primary completion date of 2026-08-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of the proposed study is to broaden our understanding on the neural effects of High Definition Transcranial Direct Current Stimulation (HD-tDCS) so that its clinical effects can be further improved.
Eligibility Criteria
Inclusion Criteria: \- All other than excluded. Exclusion Criteria: * History or susceptibility to any neurological or psychiatric diseases, particularly seizures * abnormal MRI * metal implants or a cardiac pacemaker * pregnant or breastfeeding women
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05959551 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Electricity; Effects. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05959551 currently recruiting?
Yes, NCT05959551 is actively recruiting participants. Contact the research team at ji.ko@umanitoba.ca for enrollment information.
Where is the NCT05959551 trial being conducted?
This trial is being conducted at Winnipeg, Canada.
Who is sponsoring the NCT05959551 clinical trial?
NCT05959551 is sponsored by University of Manitoba. The trial plans to enroll 100 participants.